Cue Biopharma, Inc. Gain (Loss) on Termination of Lease
Cue Biopharma, Inc. (CUE) reported Gain (Loss) on Termination of Lease of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-14
- Cue Biopharma, Inc. gain (loss) on termination of lease for the quarter ending 2026-06-30 was $0.00.
- Cue Biopharma, Inc. gain (loss) on termination of lease for the quarter ending 2026-03-31 was $10.00K.
- Cue Biopharma, Inc. gain (loss) on termination of lease for the quarter ending 2025-06-30 was $0.00.
- Cue Biopharma, Inc. gain (loss) on termination of lease for the quarter ending 2025-03-31 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $10.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |